Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Global Anti-Obesity Drugs Market 2015-2019

Published: Nov-2014 | Format: PDF | Technavio | Number of pages: 72 | Code: MRS - 1808

 

Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure.

TechNavio's analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 39.45 percent over the period 2014-2019.

Covered in this Report

The Global Anti-obesity Drugs market can be divided into two segments: Peripherally Acting Anti-obesity Drugs and Centrally Acting Anti-obesity Drugs. This report covers the present scenario and the growth prospects of the Global Anti-obesity Drugs market for the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of FDA approved drugs and OTC medications used in the treatment of obesity that are available in the market.

TechNavio's report, the Global Anti-obesity Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and EMEA regions; it also covers the Global Anti-obesity Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
Americas
APAC
EMEA

Key Vendors
Arena Pharmaceuticals
F. Hoffmann-La Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus

Other Prominent Vendors
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Merck
Norgine
Novo Nordisk
Pfizer
Rhythm Pharmaceuticals
Shionogi USA
Takeda Pharmaceutical
Zafgan

Market Driver
Increased Prevalence of Obesity
For a full, detailed list, view our report

Market Challenge
High Drug Development Costs
For a full, detailed list, view our report

Market Trend
Stiff Market Competition
For a full, detailed list, view our report

Table of Contents


1. Executive Summary

2. List of Abbreviations

3. Scope of the Report
3.1 Market Overview
3.2 Product Offerings
3.2.1 Product Profiles

4. Market Research Methodology
4.1 Market Research Process
4.2 Research Methodology

5. Introduction

6. Market Landscape
6.1 Market Overview
6.2 Market Size and Forecast
6.3 Five Forces Analysis

7. Rate of Incidence and Prevalence
7.1.1 US
7.1.2 Europe

8. Types of Obesity
8.1 Monogenic Obesity
8.2 Polygenic Obesity

9. Causes of Obesity
9.1 Unhealthy Eating Habits
9.2 Sedentary Lifestyle
9.3 Certain medications
9.4 Lack of Sleep
9.5 Pregnancy
9.6 Medical problems

10. Classification of Obesity

11. Market Segmentation by Drug Class
11.1 Peripherally Acting Anti-obesity Drugs
11.2 Centrally Acting Anti-obesity Drugs

12. Geographical Segmentation

13. Buying Criteria

14. Market Growth Drivers
14.1 Increase in Prevalence of Obesity
14.2 Increase in Sedentary Lifestyle
14.3 Significant Unmet Needs
14.4 Promising Pipeline and Upcoming Launches of New Drugs

15. Drivers and their Impact

16. Market Challenges
16.1 High Drug Development Costs
16.2 Adverse Side Effects
16.3 Alternative Treatments
16.4 Multiple Drug Recalls

17. Impact of Drivers and Challenges

18. Market Trends
18.1 Fierce Market Competition
18.2 Strict Regulations
18.3 Increase in Strategic Alliances

19. Trends and their Impact

20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2013
20.3 Other Prominent Vendors

21. Key Vendor Analysis
21.1 Arena Pharmaceuticals
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Geographical Segmentation
21.1.4 Business Strategy
21.1.5 Recent Developments
21.1.6 SWOT Analysis
21.2 F. Hoffmann-La Roche
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.3 GlaxoSmithKline
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Sales by Geography
21.3.6 Pipeline Products
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 Orexigen Therapeutics
21.4.1 Business Overview
21.4.2 Business Strategy
21.4.3 Recent Developments
21.4.4 SWOT Analysis
21.5 Vivus
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2013
21.5.4 Business Segmentation by Revenue 2012 and 2013
21.5.5 Geographical Segmentation by Revenue 2013
21.5.6 Business Strategy
21.5.7 Recent Information
21.5.8 SWOT Analysis

22. Other Reports in this Series


List of Exhibits:


Exhibit 1: Market Research Methodology
Exhibit 2: Global Anti-obesity Drugs Market 2013-2018 (US$ million)
Exhibit 3: US Prevalence of Adult Overweight and Obesity (NHANES 2011-2012)
Exhibit 4: US Prevalence of Childhood Overweight and Obesity (NHANES 2011-2012)
Exhibit 5: Types of Obesity
Exhibit 6: Causes of Obesity
Exhibit 7: Global Anti-obesity Drugs Market Segmentation by Drug Class
Exhibit 8: Global Anti-obesity Drugs Market by Geographical Segmentation 2014
Exhibit 9: Arena Pharmaceuticals: Geographical Segmentation
Exhibit 10: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 11: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 12: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 13: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
Exhibit 14: GlaxoSmithKline: Business Segmentation 2013
Exhibit 15: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 16: GlaxoSmithKline: Sales by Geography 2013
Exhibit 17: GlaxoSmithKline: Pipeline Products 2013
Exhibit 18: Vivus: Business Segmentation by Revenue 2013
Exhibit 19: Vivus: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 20: Vivus: Geographical Segmentation by Revenue 2013

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing